ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2011 Financial Results

* Reuters is not responsible for the content in this press release.

Tue Oct 18, 2011 7:30am EDT 

  IRVINE, CA, Oct 18 (MARKET WIRE) -- 
ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA), today announced it will
release third quarter 2011 financial results after the market closes on
November 1, 2011. In conjunction, the Company will host a conference call
at 4:30 p.m. Eastern Time to review the Company's commercial operations
and provide pipeline updates. 

    Date: Tuesday, November 1, 2011 
 Time: 4:30 p.m. Eastern Time

    Conference call access:
 Internet: www.istavision.com
 Domestic dial-in:
866.825.1692
 International dial-in: 617.213.8059
 Passcode: 90996630

    To access the 24-hour audio replay, U.S. and Canadian participants may
dial 888.286.8010; international participants may dial 617.801.6888. The
access code for the replay is 93234261. This conference call will be
webcast live and archived on ISTA's website until December 2, 2011. 

    About ISTA Pharmaceuticals 

    ISTA Pharmaceuticals, Inc. is a fast growing and the third largest
branded prescription eye care business in the United States with an
expanding focus on allergy therapeutics. ISTA currently markets four
products, including treatments for ocular inflammation and pain
post-cataract surgery, glaucoma and ocular itching associated with
allergic conjunctivitis. The company's development pipeline contains
additional candidates in various stages of development to treat dry eye,
ocular inflammation and pain, and nasal allergies. Headquartered in
Irvine, California, ISTA generated revenues of $156.5 million in 2010.
For additional information about ISTA, please visit the corporate website
at www.istavision.com. 

    

Investor Relations Contacts at ISTA Pharmaceuticals, Inc.:
Lauren Silvernail
949-788-5302 
lsilvernail@istavision.com

Jeanie Herbert
949-789-3159
jherbert@istavision.com

Media and Additional Investor Relations Contacts at Burns McClellan: 
Justin Jackson 
(Media)
212-213-0006
jjackson@burnsmc.com

Juliane Snowden 
(Investor Relations)
212-213-0006
jsnowden@burnsmc.com 

Copyright 2011, Market Wire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.